|
Clinical trials are a worldwide activity with clinical trial materials being shipped across many countries and continents. For the sake of patient safety, the ability to control these materials' labels at a global level is paramount. Labeling, booklets and where necessary, IFUs (Information for Use) must be safely and accurately customized not only to be printed in the appropriate local languages, but also to make certain country specific nuances, including design and regulatory requirements, are understood to ensure effective communication with users. Join us for 'Tips for Controlling Clinical Trials Labeling on a Global Scale' on Wednesday, July 10th at 11:00 a.m. EDT/4:00 p.m. BST. In this 60-minute, information-packed session, PRISYM ID explores what the industry can do to improve data security and mitigate risks involved in clinical trial local language labeling and country specific design.
|
|
|||||||
 |